Stefan ANKER - Berlin, Germany
Stefan D. Anker is Professor of (Tissue)Homeostasis in Cardiology & Metabolism (W3) at Charité University Medicine Berlin (from June 2017). He studied medicine at Charité, completed his clinical training in Germany and the UK, and obtained M.D. (1993, Charité), and Ph.D. degrees (1998, National Heart & Lung Institute, Imperial College London/UK). He was Professor of Cardiology & Cachexia Research (W2) at Charité (2002- 14), and Professor of Innovative Clinical Trials (W3) in Göttingen (2014-17).
Dr. Anker has authored more than 1,300 articles (total citations: >345,000, h-index: 221, papers with >500 citations: 97; source: GoogleScholar, 18. April 2025) and was named Highly Cited Researcher 2015–2023.
For his work Dr. Anker has won several prizes, including the 2018 Copernicus Prize of German DFG & Polish FNP. Dr. Anker was awarded a Doctor honoris causa of Medical University Wroclaw / Poland (October 2020) and of Semmelweis University Budapest / Hungary (November 2021).
Dr. Anker obtained a number of fellowships & grants, incl. from the NIH and the EU. He received grants for several IITs (3 currently running) from DZHK Germany & several industries.
Dr. Anker was Vice President of the European Society of Cardiology (ESC, 2016-18), serving on the Board 2012-2018. Dr. Anker was President of the Heart Failure Association (HFA) of the ESC (2012-14). From 2014 to 2022 he was founding Editor-in-Chief of the open access journal ESC Heart Failure. He was member of several ESC Guideline groups (e.g. for Heart Failure in 2012 & 2016).
Dr. Anker is the President of the International Society on Sarcopenia, Cachexia and Wasting Disorders since 2008 (SCWD – see www.cachexia.org). Dr. Anker is founding Editor-in-Chief of the Journal of Cachexia, Sarcopenia and Muscle since 2010 (JCSM, 2023-IF: 9.4, see www.jcsm.info).
Dr. Anker was and is member of >30 international clinical trial steering committees, chairing or co-chairing several (incl. FAIR-HF2 [JAMA’25], RESHAPE-HF2 [NEJM’24], EMPEROR-Preserved [NEJM’21], FAIR-HF [NEJM’09], RELIEVE-HF, DIAMOND-HF, TIM-HF, ACT-ONE, AUGMENT-HF & BACH).